At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
L-Methyl folate (a form of folic acid) is essential for DNA synthesis, cell division, and the formation of red blood cells
Personalized Protocol Dosing, administration route (subcutaneous injection or oral, depending on your goals), frequency, and duration are tailored to your specific situation not copied from a Reddit thread
That's what I'm taking away from everything you're telling me
PMC 1410962
Effects in Preclinical Models Preclinical research has also explored several additional pathways mediated by the GHS receptor: Metabolic effects: Ipamorelin has been investigated as a ghrelin receptor agonist in models of gastroparesis, where it significantly accelerated gastric emptying and improved gastrointestinal motility
:max_bytes(150000):strip_icc()/VWH-GettyImages-2059065209-7ab09bdd0be8409493ace4364fccf792.jpg)
